Bauer H W, Bach D
Urol Int. 1986;41(2):139-44. doi: 10.1159/000281183.
The measurement of prostaglandin E2 (PGE2) concentrations in the serum and prostatic fluid of healthy men, patients with prostatic hyperplasia and of patients with prostatitis was attempted and correlated to the state of disease, respectively. PGE2-concentrations with prostatic fluid of healthy men were found to be significantly lower than in patients with prostatitis. Corresponding to the course of treatment concentrations normalized, being favorably influenced by sitosterin as an adjuvant medication. Compared to healthy men, PGF2 concentrations in the prostatic fluid of patients with hyperplasia of the prostate incline to lower levels.
尝试测量健康男性、前列腺增生患者和前列腺炎患者血清及前列腺液中前列腺素E2(PGE2)的浓度,并分别将其与疾病状态相关联。发现健康男性前列腺液中的PGE2浓度显著低于前列腺炎患者。随着治疗过程,浓度恢复正常,作为辅助药物的谷甾醇对其有积极影响。与健康男性相比,前列腺增生患者前列腺液中的PGF2浓度倾向于较低水平。